AMFI Registered Mutual Fund Distributor
                Fundsupermart.com | Global   
SEARCH 
   GETTING STARTED         |  TRANSACTIONS     |  MY INVESTMENTS     |  RESEARCH     |  MUTUAL FUND     |  NRI     |  FORUM     |  CONTACT US     |  FAQ     | 
  Help us contact you
  *   
  *   
     
 
Factsheets
 Fund Card 
Buy
Glossary
Offer Document
Performance
Share
Print
SBI PHARMA FUND- GROWTH Risk Rating: 10

INVESTMENT OBJECTIVE

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors. There are four sub-funds dedicated to specific sectors viz. IT, Pharmaceuticals, FMCG, Contra sub fund for investment in stocks currently out of favour and Emerging Business Fund (EBF) to participate in the growth potential presented by various companies that are considered emergent and have export orientation/outsourcing opportunities or are globally competitive by investing in the stocks representing such companies. The fund may also evaluate emerging businesses with growth potential and domestic focus.
Fund Category Equity
Fund Class Pharmaceuticals
Fund Type Open-Ended
Options Growth
 
FUND INFO
Launch Date July 14, 1999
Launch Price Rs. 10.00
Latest NAV Price (Click here for price history) Rs. 66.34 (May 17, 2013)
Fundsupermart Risk Rating 10-Highest Risk
 
Minimum Initial Investment Rs. 2,000 / -
Minimum Subsequent Investment Rs. 500 / -
Minimum Redemption Amount Rs. 500
Minimum Holding Period -
Transaction Time for Redemption 1:50 PM
Entry Load -
Exit Load 1% if redeemed/switched within 1 year from the date of investment; NIL if redeemed/switched after 1 year from the date of investment.
 
Fund House

SBI FUNDS MANAGEMENT PRIVATE LIMITED View Fund Manager
 
Fund Factsheet and Offer Document
 
Fact Click here for the Fund Factsheet
 
Offer Click here for the Offer Document
 
Get Acrobat Click here to download Adobe Acrobat.
 
FUND PERFORMANCE (ANNUALIZED RETURNS)
Period 1 wk 1 mth 3 mth 6 mth 1 yr 3 yr 5 yr since inception
NAV Returns (%) - INR 3.88 7.0 13.6 15.9 36.2 19.3 - -
Performance figures (as of May 17, 2013)
The performance figures in the table above are calculated using NAV prices, assuming growth option. Performance figures of over 1 year are annualised.(Eg. A 33.1% gain in 3 years works out to a 10% gain per year when annualised.)
 
 
 
Click here to see how the fund has performed against other funds or an index.
 
OTHER PERFORMANCE DATA
Calendar Year 2012 2011 2010 2009 2008
SBI PHARMA FUND- GROWTH (%) 37.06 -5.54 - - -
The performance figures in the table above are calculated using NAV, assuming Growth option. Performance figures of over 1 year are annualised.(Eg. A 33.1% gain in 3 years works out to a 10% gain per year when annualised.)
 
 
3 yr Annualised Volatility 13.43
3 yr Sharpe ratio 0.95
The above figures (as of May 17, 2013)
 

Please note:

  1. Unit price is the NAV price, sales charges are not included.
  2. Investment involves risk. The price of securities may go down as well as up, and under certain circumstances an investor may sustain a total or substantial loss of investment. Past performance is not necessarily indicative of the future or likely performance of the fund. Investors should read the relevant fund's prospectus for details before making any investment decision. An Investor should make an appraisal of the risks involved in investing in these products and should consult their own independent and professional advisors, to ensure that any decision made is suitable with regards to their circumstances and financial position.
  3. This fact sheet is compiled by fundsupermart.com from the individual fund management company's public information material, and meant for information only. Whilst all attempts have been made by fundsupermart.com to present the information accurately and completely, mistakes and omissions do sometimes occur. Readers are advised to read the Offer Document/SID/SAI before making any investment decision. It is important that you read our disclaimers.
  4. Fund's performance refers to the performance of the growth option of this scheme.